ArticleIntestinal research2018

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India.

Ashish Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.